Traditional MedicareAdministrativeHigh impact
Senior Services News Vol. 6, No. 02
New Jersey Medicaid·NJ · Endocrinology, Oncology·Provider Notice
Effective date
Apr 2, 2002
We identified it
Jun 20, 2026
Summary
New Jersey's PAAD program now requires pharmacy providers to comply with Medicare Part B DMEPOS supplier requirements and complete EDI enrollment to continue participation. Pharmacies must obtain ICD-9 diagnosis codes for Medicare-covered drugs and follow specific documentation requirements for diabetic supplies and immunosuppressive drugs.
Action Required
By April 2, 2002: New Jersey pharmacy providers must submit completed EDI enrollment forms to continue PAAD/Senior Gold participation. Obtain ICD-9 diagnosis codes from prescribers for all Medicare-covered drugs. For diabetic supplies, add ZX modifier for insulin-dependent patients or KS modifier for non-insulin patients. Maintain written physician orders, Drug Information Forms for immunosuppressive drugs, and assignment of benefits documentation on file. Non-compliance will result in suspension from PAAD programs.